Trial Profile
Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A to Improve Gait in Hemiparesis. A Randomized Multicenter Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Brain injuries; Paresis
- Focus Therapeutic Use
- Acronyms GENUFLEX
- 10 Nov 2019 Status changed from recruiting to completed.
- 21 Apr 2017 New trial record